Director McFarland sells 16,372 shares of CRC at $64.83; stock up 15.6% in 30d, 34.9% in 90d; prior CRC sales consistently gained post-trade.
Director Mark Allen McFarland sold 16,372 shares (16.4K shares) at $64.83, reducing his holdings by -17.7% from 92,637 to 76,265 shares. The transaction occurred near the 52-week high of $64.74, with the stock having appreciated +15.6% over the preceding 30 days and +34.9% over 90 days, reflecting strong recent momentum. However, his prior five trades at CRC showed a consistent pattern of poor timing at the 90-day mark: all five previous sells resulted in positive 90-day returns (ranging from +8.4% to +10.6%), meaning the stock rose after his selling, indicating he sold ahead of continued gains rather than ahead of declines. This current sale at a near-peak price following substantial recent appreciation warrants observation of whether this transaction breaks or continues that pattern of sub-optimal exit timing at this security.